NEWS
View news from our Featured Companies.
PolyPid to Report First Quarter 2023 Financial Results and Operational Highlights on May 10, 2023
PETACH TIKVA, Israel, April 26, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its first quarter 2023 financial results and operational...
InfuSystem Announces Distribution Agreement with Genadyne for Negative Pressure Wound Therapy Systems
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
Jewett-Cameron to close Jewett-Cameron Seed Company
NORTH PLAINS, Ore., April 25, 2023 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF) has made the difficult decision to close its wholly-owned subsidiary Jewett-Cameron Seed Company ("JCSC") effective August 31, 2023. JCSC processes, distributes and stores...
Reviva Pharmaceuticals to Host Key Opinion Leader Event on Brilaroxazine (RP5063) in Phase 3 Clinical Trials for Schizophrenia
Virtual event on Tuesday, May 2, 2023 at 11:00am ET will feature key opinion leader (KOL) Larry Ereshefsky, PharmD, BCPP, FCCP, Chief Scientific Officer, Follow the MoleculeCUPERTINO, Calif., April 25, 2023 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH)...
PolyPid to Participate in Upcoming Investor Conferences
PETACH TIKVA, Israel, April 24, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that members of management will participate in the following upcoming investor...
Precision Optics to Participate in the Planet MicroCap Showcase: VEGAS 2023 on April 26-27, 2023
GARDNER, Mass., April 21, 2023 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced Dr. Joe Forkey, CEO, will be participating in the Planet...
Inherited Retinal Disease Expert, Mark Pennesi, M.D., Ph.D., Joins Kiora Pharmaceuticals’ Scientific Advisory Board
Encinitas, California--(April 21, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed Mark Pennesi, M.D., Ph.D., the Kenneth C. Swan Endowed Professor in Ophthalmology and Molecular and Medical Genetics and the Chief of the Paul H. Casey Ophthalmic Genetics...
Reviva Pharmaceuticals to Present on Novel Serotonin-Dopamine Stabilizer Brilaroxazine at the 78th Annual Scientific Convention of the Society of Biological Psychiatry
CUPERTINO, Calif., April 20, 2023 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Precision Optics Announces $1.3 Million Product Expansion Development Agreement for Next Generation Urological Endoscopy Program
GARDNER, Mass., April 19, 2023 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the receipt of an initial product development order for a...
Scientific Industries Reports Financial Results for Six Month Transition Period Ended December 31, 2022; Discloses Non-Cash Restatement of Certain Previously Issued Financial Statements
LAB EQUIPMENT OPS' VIVID PILL COUNTER POSTS RECORD SALESBIOPROCESSING OPS LAUNCHES FIRST PRODUCTCOMPANY CHANGES TO CALENDAR YEAR ENDNO IMPACT ON CASH, CASH FLOWS OR BUSINESS OPERATIONS FROM RESTATEMENTBOHEMIA, NY / April 17, 2023 / Scientific Industries, Inc....
Precision Optics Appoints Mahesh Lawande as Chief Operating Officer
GARDNER, Mass., April 17, 2023 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of medical device and aerospace/defense...
Kiora Pharmaceuticals Initiates Phase 2 Trial of KIO-101 for the Treatment of Ocular Presentation of Autoimmune Diseases
Encinitas, California--(April 17, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) enrolled the first patient in its Phase 2 trial of KIO-101 in the treatment of the Ocular Presentations of Rheumatoid Arthritis and other autoimmune diseases (OPRA+). This clinical trial is...
PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
PETACH TIKVA, Israel, April 14, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced it has received a letter from the Listing Qualifications staff of The Nasdaq Stock...
Jewett-Cameron Announces 2nd Quarter Financial Results
NORTH PLAINS, Ore., April 13, 2023 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF) today reported financial results for the second quarter and six month periods of fiscal 2023 ended February 28, 2023. Sales for the second quarter of fiscal 2023 were $8.14...
SenesTech and ContraPest® Featured at the Animal Care Expo in New Orleans
Growth in the Animal Care Segment of Pest Control Continues to Be Strong PHOENIX, April 11, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023
PORTLAND, Maine, April 05, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
Mogo Announces that Coinsquare has entered into a Business Combination Agreement involving Coinsquare, WonderFi and Coinsmart, creating Canada’s leading public and only fully regulated crypto asset trading platform
Mogo is Coinsquare's largest shareholder and is expected to be the largest shareholder of the Combined Company on closing The Combined Company will have a user base in excess of 1.65 million Canadians VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO)...
ARIANNE PHOSPHATE REDUCES DEBT AND ISSUES SHARES AS INTEREST PAYMENT
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, March 31, 2023 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul project...
PolyPid Announces Closing of Underwritten Public Offering, Including Full Exercise of Overallotment Option, and Concurrent Private Placement with $11.4 Million in Aggregate Gross Proceeds
Company Also Restructures Existing Kreos Loan, Deferring Over $3 Million of Repayment PETACH TIKVA, Israel, March 31, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, announced today...
Cadrenal Therapeutics Provides Fiscal Year 2022 Corporate Update
PONTE VEDRA, Fla., March 30, 2023 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) a biopharmaceutical company focused on developing tecarfarin, a late-stage novel cardiorenal therapy with orphan drug and Fast Track designations, today provided a corporate update in...
Reviva Pharmaceuticals Holdings, Inc. Reports Full Year 2022 Financial Results and Recent Business Highlights
- Topline data for pivotal Phase 3 trial evaluating brilaroxazine for the treatment of schizophrenia remains on track for mid-2023 - - Completed majority of non-clinical and clinical prelaunch measures for brilaroxazine New Drug Application (NDA) submission - -...
ARIANNE PHOSPHATE RECEIVES ENGINEERING STUDY UPDATING ITS LAC À PAUL CAPEX
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, March 30, 2023 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FSE: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul project in...
Kiora Announces the Acceptance of Late-Breaking Abstract on Phase 1b Study of KIO-301 in Retinitis Pigmentosa at The American Society of Neuroradiology 2023 Meeting
Encinitas, California--(March 30, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced its late-breaking abstract detailing functional Magnetic Resonance Imaging (fMRI) results from the ABACUS Phase 1b study of KIO-301 in patients...
TIME Magazine Takes a Closer Look at ContraPest as a Solution to Global Rat Infestations
PHOENIX, March 29, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, were featured in TIME...
PolyPid Announces Pricing of $6.2 Million Underwritten Public Offering of Ordinary Shares and Concurrent $4.4 Million Private Placement of Pre-Funded Warrants
PETACH TIKVA, Israel, March 29, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, announced today the pricing of an underwritten public offering of 14,660,000 ordinary shares, no par...